PAM
BLRX
PVG Asset Management’s BioLineRX BLRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-157,215
| Closed | -$84.3K | – | 51 |
|
|
2024
Q3 | $84.3K | Buy |
157,215
+33,635
| +27% | +$18K | 0.34% | 39 |
|
|
2024
Q2 | $70.4K | Buy |
+123,580
| New | +$70.4K | 0.28% | 35 |
|
|
2023
Q4 | $97.1K | Buy |
+61,840
| New | +$97.1K | 0.47% | 29 |
|
|
2023
Q3 | – | Sell |
-61,840
| Closed | -$98.6K | – | 29 |
|
|
2023
Q2 | $98.6K | Sell |
61,840
-66,885
| -52% | -$107K | 0.43% | 31 |
|
|
2023
Q1 | $114K | Buy |
+128,725
| New | +$114K | 0.37% | 31 |
|
|
2022
Q4 | – | Sell |
-47,860
| Closed | -$44.3K | – | 39 |
|
|
2022
Q3 | $44.3K | Buy |
+47,860
| New | +$44.3K | 0.17% | 31 |
|
|
2021
Q4 | $327K | Buy |
160,360
+83,850
| +110% | +$171K | 1.2% | 20 |
|
|
2021
Q3 | $210K | Buy |
+76,510
| New | +$210K | 0.63% | 31 |
|